# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
MLEC: 135% | Moolec Science shares are trading higher after the company announced that it received USDA approval for plant-grow...
B of A Securities analyst Sachin Salgaonkar upgrades Sea (NYSE:SE) from Neutral to Buy and raises the price target from $62 ...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over